文献速递免疫规划妇幼与学校卫生

流感疫苗不良事件关注点因疫苗类型和品牌而异:八个季节(2010-2018)的哨点网络研究

Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010-2018).
PubMed 文献 · Vaccine · 2020-04-13

该研究利用皇家全科医师学院(RCGP)研究与监测中心哨点网络数据库2010-2018年数据,采用回顾性队列和自我对照病例系列设计,比较不同流感疫苗类型的不良事件关注点(AEI)报告相对发生率。结果显示四价流感疫苗(QIV)AEI相对发生率高于三价流感疫苗(TIV),而减毒活疫苗(LAIV)和细胞培养疫苗较低,孕妇和5岁以下儿童AEI相对发生率升高。

要点

  • QIV的AEI相对发生率为1.14(95%CI 1.10-1.18,p<0.01),高于TIV。
  • LAIV的AEI相对发生率为0.60(95%CI 0.63-0.68,p<0.001),低于TIV。
  • 孕妇AEI相对发生率1.78(95%CI 1.62-1.95),5岁以下儿童1.76(95%CI 1.56-1.99)。

核心结论

  • 常规哨点网络数据可用于比较不同疫苗类型之间的AEI,并可能提供一种观察疫苗获益-风险随时间的 consistent 方法。

研究设计与样本

  • 回顾性队列研究,使用皇家全科医师学院(RCGP)研究与监测中心哨点网络数据库2010-2018年计算机化医疗记录数据(N=848,375)。
  • 提取疫苗接种暴露数据(n=3,121,334)和接种后七天内欧洲药品管理局(EMA)指定的AEI就诊数据(430,029名 unique 个体的1,488,870次就诊)。
  • 采用自我对照病例系列设计,使用条件化观察不良事件的似然估计方法,假设每个暴露期和年龄区间为非齐次泊松强度过程。

主要发现

  • QIV与AEI相对发生率1.14相关(95%CI 1.10-1.18,p<0.01),但暴露年数有限。
  • LAIV的AEI相对发生率为0.60(95%CI 0.63-0.68,p<0.001),低于TIV。
  • 细胞培养疫苗的AEI相对发生率为0.78(95%CI 0.61-0.99,p=0.04),低于TIV。
  • AEI随季节变化:皮疹和肌肉骨骼疾病在2014/15季节尤为明显,呼吸系统疾病在2016/17季节明显。
  • 所有季节分析中,孕妇AEI相对发生率升高至1.78(95%CI 1.62-1.95),5岁以下儿童为1.76(95%CI 1.56-1.99)。

局限性

  • QIV暴露年数有限。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Influenza contributes significantly to the burden of disease worldwide; the United Kingdom has a policy of vaccination across all ages. Influenza vaccinations are known to be associated with common minor adverse events of interest (AEIs). The European Medicines Agency (EMA) recommends ongoing surveillance of AEIs following influenza vaccination to monitor common and detect infrequent but important AEIs. METHODS: A retrospective cohort study using computerised medical record data from the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) sentinel network database 2010-2018 (N = 848,375). We extracted data about vaccine exposure (n = 3,121,334) and consultations for AEIs within seven days of receiving vaccinations specified by the EMA (1,488,870 consultations by 430,029 unique individuals). We used a self-case series design which employs a likelihood estimation method using conditioning of observed adverse events. Such a model assumes non-homogenous Poisson intensity processes for each exposure period and age interval. We compared AEI between QIV and TIV reporting relative incidence (RI) of AEIs. A RI < 1 signified lower AEI rate compared to TIV. RESULTS: QIV was associated with a RI of AEIs of 1.14 (95%CI, 1.10-1.18, p < 0.01), though the number of years exposure was limited. By way of contrast, LAIV had a lower rate 0.60 (95%CI 0.63-0.68, p < 0.001). Cellular manufacture was also associated with a lower rate 0.78 (95%CI 0.61-0.99, p = 0.04). AEIs varied by season: Rash and musculoskeletal conditions are particularly pronounced in the 2014/15 season and respiratory conditions in 2016/17. In an analysis of all seasons, we found an elevated relative incidence of AEIs of 1.78 (95%CI, 1.62-1.95) in pregnant women and 1.76 (95%CI, 1.56 - 1.99) in children under 5 years. CONCLUSION: Routine sentinel network data can be used to contrast AEIs between vaccine types and may provide a consistent method of observation of vaccine benefit-risk over time.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cross JW, Joy M, McGee C, et al. Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010-2018). Vaccine. 2020. PMID: 32299719. doi:10.1016/j.vaccine.2020.03.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。